Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allopregnanolone in Postpartum Depression
Graziano Pinna, Felipe Borges Almeida, John M. Davis
Frontiers in Global Women s Health (2022) Vol. 3
Open Access | Times Cited: 25

Showing 25 citing articles:

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential
Ravinder Naik Dharavath, Celeste Pina‐Leblanc, Victor M. Tang, et al.
Frontiers in Neural Circuits (2023) Vol. 17
Open Access | Times Cited: 18
Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
Qian Gao, Wei Sun, Yue-Rui Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Forty Years Searching for Neurosteroid Binding Sites on GABAA Receptors
Martin Mortensen, Damian P. Bright, Juliane Fagotti, et al.
Neuroscience (2024)
Closed Access | Times Cited: 5
Investigating the impact of endocrine-disrupting compounds on antepartum mental health at the Nexus of genetic insights and maternal-fetal outcomes: A prospective study
S Aishwarya, V.M. Vinodhini, P. Renuka, et al.
General Hospital Psychiatry (2025) Vol. 94, pp. 174-183
Closed Access
Exploring the clinical potentials of zuranolone in managing postpartum depression: A new therapeutic horizon
Abdulqadir J. Nashwan, Syeda Tayyaba Rehan, Laiba Imran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 132, pp. 110983-110983
Open Access | Times Cited: 3
Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms
Richelle D. Björväng, Ylva Walldén, Emma Fransson, et al.
Psychoneuroendocrinology (2024) Vol. 164, pp. 107009-107009
Open Access | Times Cited: 3
Allopregnanolone in the Peripartum: Correlates, Concentrations, and Challenges – A Systematic Review
Maria Katharina Grötsch, Ulrike Ehlert
Psychoneuroendocrinology (2024) Vol. 166, pp. 107081-107081
Open Access | Times Cited: 3
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options
Rainer Rupprecht, Arpit Kumar Pradhan, Marco Kufner, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 7, pp. 1477-1487
Closed Access | Times Cited: 14
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Shayam Suseelan, Graziano Pinna
Advances in clinical chemistry (2022), pp. 1-67
Closed Access | Times Cited: 14
The importance of translationally evaluating steroid hormone contributions to substance use
Erin E. Maher, Ashley M. Strzelecki, Jessica Weafer, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101059-101059
Open Access | Times Cited: 7
C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10
Michaela Hanzlova, Barbora Slavı́ková, Marina Morozovova, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 12116-12124
Open Access | Times Cited: 2
Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes
Simona Scheggi, Luca Concas, Sara Corsi, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105842-105842
Open Access | Times Cited: 2
Neurosteroids as positive and negative allosteric modulators of ligand-gated ion channels: P2X receptor perspective
Sonja Sivcev, Eva Kudová, Hana Zemková
Neuropharmacology (2023) Vol. 234, pp. 109542-109542
Closed Access | Times Cited: 6
(3α,5α)3-Hydroxypregnan-20-one (3α,5α-THP) Regulation of the HPA Axis in the Context of Different Stressors and Sex
Giorgia Boero, Ryan E. Tyler, Todd K. O’Buckley, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 9
Brexanolone Treatment in a Real-World Patient Population
Meg Guard, Alyssa K. Labonte, M Rodriguez- Mendoza, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
The novel rapid-acting neurosteroid-based antidepressant generation
Aksu Günay, Graziano Pinna
Current Opinion in Endocrine and Metabolic Research (2022) Vol. 24, pp. 100340-100340
Closed Access | Times Cited: 7
Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems
Graziano Pinna
Journal of Neuroendocrinology (2022) Vol. 35, Iss. 2
Closed Access | Times Cited: 6
Exploring Novel Therapeutic Approaches for Depressive Disorders: The Role of Allopregnanolone Agonists
Najeeha Ahmad Bhatti, Anna Jobilal, Kainat Asif, et al.
Cureus (2023)
Open Access | Times Cited: 2
Stereoselective Reduction of Steroidal 4-Ene-3-ketones in the Presence of Biomass-Derived Ionic Liquids Leading to Biologically Important 5β-Steroids
Eszter Szánti‐Pintér, Lada Jirkalová, Radek Pohl, et al.
ACS Omega (2024) Vol. 9, Iss. 6, pp. 7043-7052
Open Access
Neurobiology of Postpartum Depression: Critical Aspects
Pragya Lodha, Avinash De Sousa
Annals of Indian Psychiatry (2024) Vol. 8, Iss. 3, pp. 173-176
Open Access
Neurosteroid replacement approaches for improving outcomes after compromised pregnancies and preterm birth
Jonathan J. Hirst, Hannah K. Palliser, Carlton L. Pavy, et al.
Frontiers in Neuroendocrinology (2024), pp. 101169-101169
Open Access
Impact of premenstrual syndrome and premenstrual dysphoric disorder on maternal antenatal depression
Naoyuki Ihara, Yoko Sato, Subaru Ikeda, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0315628-e0315628
Open Access
Drugs possessing aryloxypropanamine pharmacophore, duloxetine, dapoxetine and propranolol, increase allopregnanolone in rat brain: Possible involvement of allopregnanolone in their central nervous system effects
Shoichi Nishimoto‐Kusunose, Ayaka Hirakawa, Asuka Tanaka, et al.
Steroids (2023) Vol. 198, pp. 109272-109272
Closed Access | Times Cited: 1
Redefining Postpartum Depression Treatment: The Clinical Potential of Zuranolone
Abdulqadir J. Nashwan, Syeda Tayyaba Rehan, Laiba Imran, et al.
Asian Journal of Psychiatry (2023) Vol. 91, pp. 103849-103849
Closed Access | Times Cited: 1
Page 1

Scroll to top